Chemo-immunotherapy, Hypo-fractionated RT and Maintenance Immunotherapy for Stage III NSCLC.
Clinical trial NCT05128630 · UNKNOWN
Trial details
- NCT number
- NCT05128630
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-28
- Primary completion
- 2024-11-28
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.